Overview

Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

Status:
NOT_YET_RECRUITING

Trial end date:
2027-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this research study is to develop and pilot a multiple health behavior change intervention for weight loss and smoking cessation using medication (Naltrexone + Bupropion) and behavior therapy in adults seeking bariatric surgery.

Phase:

PHASE1

Details

Lead Sponsor:

Yale University

Collaborator:

American Society for Metabolic and Bariatric Surgery

Treatments:

Cognitive Behavioral Therapy
Naltrexone